Yazar "Barnett, Michael" için listeleme
-
Cladribine versus fingolimod, natalizumab and interferon for multiple sclerosis
Kalincik, Tomas; Jokubaitis, Vilija; Spelman, Tim; Horakova, Dana; Havrdova, Eva; Trojano, Maria; Barnett, Michael (Sage Publications Ltd, 2018)Objective: This propensity score-matched analysis from MSBase compared the effectiveness of cladribine with interferon , fingolimod or natalizumab. Methods: We identified all patients with relapse-onset multiple sclerosis, ... -
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Tao, Chunrong; Simpson, Steve; van der Mei, Ingrid; Blizzard, Leigh; Havrdova, Eva; Horakova, Dana; Barnett, Michael (Bmj Publishing Group, 2016)Background Age at onset (AAO) in multiple sclerosis (MS) is an important marker of disease severity and may have prognostic significance. Understanding what factors can influence AAO may shed light on the aetiology of this ...
